Cargando…

L1 and HERV-W retrotransposons are hypomethylated in human ovarian carcinomas

Wide-spread hypomethylation of CpG dinucleotides is characteristic of many cancers. Retrotransposons have been identified as potential targets of hypomethylation during cellular transformation. We report the results of an preliminary examination of the methylation status of CpG dinucleotides associa...

Descripción completa

Detalles Bibliográficos
Autores principales: Menendez, Laura, Benigno, Benedict B, McDonald, John F
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2004
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC411053/
https://www.ncbi.nlm.nih.gov/pubmed/15109395
http://dx.doi.org/10.1186/1476-4598-3-12
_version_ 1782121402873151488
author Menendez, Laura
Benigno, Benedict B
McDonald, John F
author_facet Menendez, Laura
Benigno, Benedict B
McDonald, John F
author_sort Menendez, Laura
collection PubMed
description Wide-spread hypomethylation of CpG dinucleotides is characteristic of many cancers. Retrotransposons have been identified as potential targets of hypomethylation during cellular transformation. We report the results of an preliminary examination of the methylation status of CpG dinucleotides associated with the L1 and HERV-W retrotransposons in benign and malignant human ovarian tumors. We find a reduction in the methylation of CpG dinucleotides within the promoter regions of these retroelements in malignant relative to non-malignant ovarian tissues. Consistent with these results, we find that relative L1 and HERV-W expression levels are elevated in representative samples of malignant vs. non-malignant ovarian tissues.
format Text
id pubmed-411053
institution National Center for Biotechnology Information
language English
publishDate 2004
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-4110532004-05-19 L1 and HERV-W retrotransposons are hypomethylated in human ovarian carcinomas Menendez, Laura Benigno, Benedict B McDonald, John F Mol Cancer Short Communication Wide-spread hypomethylation of CpG dinucleotides is characteristic of many cancers. Retrotransposons have been identified as potential targets of hypomethylation during cellular transformation. We report the results of an preliminary examination of the methylation status of CpG dinucleotides associated with the L1 and HERV-W retrotransposons in benign and malignant human ovarian tumors. We find a reduction in the methylation of CpG dinucleotides within the promoter regions of these retroelements in malignant relative to non-malignant ovarian tissues. Consistent with these results, we find that relative L1 and HERV-W expression levels are elevated in representative samples of malignant vs. non-malignant ovarian tissues. BioMed Central 2004-04-26 /pmc/articles/PMC411053/ /pubmed/15109395 http://dx.doi.org/10.1186/1476-4598-3-12 Text en Copyright © 2004 Menendez et al; licensee BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL.
spellingShingle Short Communication
Menendez, Laura
Benigno, Benedict B
McDonald, John F
L1 and HERV-W retrotransposons are hypomethylated in human ovarian carcinomas
title L1 and HERV-W retrotransposons are hypomethylated in human ovarian carcinomas
title_full L1 and HERV-W retrotransposons are hypomethylated in human ovarian carcinomas
title_fullStr L1 and HERV-W retrotransposons are hypomethylated in human ovarian carcinomas
title_full_unstemmed L1 and HERV-W retrotransposons are hypomethylated in human ovarian carcinomas
title_short L1 and HERV-W retrotransposons are hypomethylated in human ovarian carcinomas
title_sort l1 and herv-w retrotransposons are hypomethylated in human ovarian carcinomas
topic Short Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC411053/
https://www.ncbi.nlm.nih.gov/pubmed/15109395
http://dx.doi.org/10.1186/1476-4598-3-12
work_keys_str_mv AT menendezlaura l1andhervwretrotransposonsarehypomethylatedinhumanovariancarcinomas
AT benignobenedictb l1andhervwretrotransposonsarehypomethylatedinhumanovariancarcinomas
AT mcdonaldjohnf l1andhervwretrotransposonsarehypomethylatedinhumanovariancarcinomas